The history of Viagra and its creator , copyright, presents a complex picture for prospective investors. While the iconic drug initially fueled enormous revenues , its protection has lapsed , leading to generic alternatives flooding the arena. This reduction in value presents a significant hurdle for copyright and any portfolio considering a large